These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3867767)

  • 1. [CA 125 in patients with ascites].
    Muto H
    Nihon Shokakibyo Gakkai Zasshi; 1985 Sep; 82(9):2150. PubMed ID: 3867767
    [No Abstract]   [Full Text] [Related]  

  • 2. CA 125 (ovarian tumour-associated antigen) in ascitic liver diseases.
    Bergmann JF; Beaugrand M; Labadie H; Bidart JM; Bohuon C
    Clin Chim Acta; 1986 Mar; 155(2):163-5. PubMed ID: 3009058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Simultaneous determination of Ca 125 and D-dimer in plasma and ascites in ovarian cancer].
    Schröck R; Hafter R; Graeff H; Schmid L
    Onkologie; 1985 Oct; 8(5):260-2. PubMed ID: 2999668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of CA 125 in patients with benign and malignant ascites.
    Bergmann JF; Bidart JM; George M; Beaugrand M; Levy VG; Bohuon C
    Cancer; 1987 Jan; 59(2):213-7. PubMed ID: 3026603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA-19-9 and CEA in the differential diagnosis of isolated liver metastases compared to clinical laboratory tests.
    Lorenz M; Hottenrott C; Baum RP; Maul FD; Kirkowa-Reimann M; Hör G; Encke A
    Nucl Med Commun; 1987 Oct; 8(10):787-96. PubMed ID: 3481063
    [No Abstract]   [Full Text] [Related]  

  • 6. [Measurement of CA 19-9 in patients with benign liver cyst].
    Okazaki K; Morita M; Sakamoto Y; Ido E; Fujikawa M
    Nihon Shokakibyo Gakkai Zasshi; 1984 Jun; 81(6):1493. PubMed ID: 6590903
    [No Abstract]   [Full Text] [Related]  

  • 7. [CA125 in patients with pleural effusion--in comparison with ascites patients].
    Kawabe T; Hirano M; Mohri M; Sugimoto T; Nagata Y; Hisada M; Muto H; Unuma T; Momose T; Naka H
    Rinsho Byori; 1987 Aug; 35(8):905-9. PubMed ID: 3480365
    [No Abstract]   [Full Text] [Related]  

  • 8. [Carbohydrate antigen (CA-19-9) in the blood serum of patients with benign and malignant liver diseases].
    Ametov AS; Kasatkin IuN; Mit'kov VV; Gur'eva IV
    Med Radiol (Mosk); 1985 Mar; 30(3):39-41. PubMed ID: 3856723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CA-50: evaluation of a new tumor marker in the diagnosis of neoplastic pathologies of the gastrointestinal tract].
    Pecchio F; Ricci E; Rapellino M; Oliaro A; Adamo MR; Marzola G; Piantino P
    Minerva Med; 1987 Feb; 78(3):141-4. PubMed ID: 3469541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary application of carbohydrate antigen CA-50 radioimmunoinhibition test in diagnosing and monitoring cancers].
    Chen ZZ; Fan ZF; Su P
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):436-8. PubMed ID: 2838242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum CA 50 in benign non-hepatic diseases].
    Genollá J; Mañé S; Gris JM; Ruibal A
    Med Clin (Barc); 1987 Feb; 88(5):214. PubMed ID: 3470582
    [No Abstract]   [Full Text] [Related]  

  • 12. [High Ca 125 serum level in benign ascites or pleural effusion].
    Mezger J; Häussinger KE; Wilmanns W; Lamerz R
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):463-5. PubMed ID: 3476336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of serum levels of CA-125 in patients with digestive diseases].
    Takemori Y; Sawabu N; Satomura Y; Ohta H; Watanabe H; Kawakami H; Okai T; Takahashi Y; Mai M; Hattori N
    Nihon Shokakibyo Gakkai Zasshi; 1987 Oct; 84(10):2386-92. PubMed ID: 3481416
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer antigen 125 levels in serum can predict the recurrence of ascites in patients with cirrhosis of the liver.
    Aguilar-Reina J; Rey-Romero C; Ortega-Viñas M; Hernandez-Pascual A; Sayago-Mota M
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():163-5. PubMed ID: 2083930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease.
    Habib NA; Hershman MJ; Haberland F; Papp L; Wood CB; Williamson RC
    Br J Cancer; 1986 May; 53(5):697-9. PubMed ID: 3459510
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum CA 1,25 in patients with non-ovarian tumors. Evidence of a relation between the increase of the antigen and hepatic disease].
    Ruibal A; Siurana R; Encabo G; Cuartero A
    Med Clin (Barc); 1985 Mar; 84(9):376-7. PubMed ID: 3857424
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases.
    Molina R; Filella X; Bruix J; Mengual P; Bosch J; Calvet X; Jo J; Ballesta AM
    Clin Chem; 1991 Aug; 37(8):1379-83. PubMed ID: 1868598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CA 19-9 in benign diseases of the gastrointestinal tract].
    Klapdor R
    Dtsch Med Wochenschr; 1986 Jun; 111(26):1039. PubMed ID: 3459644
    [No Abstract]   [Full Text] [Related]  

  • 19. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
    Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
    Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The contribution of CA 19-9 in the differential diagnosis between chronic pancreatitis and cancer of the pancreas].
    Van Gossum M; Delanghe A; Gerard M; Delcourt A; Deltenre M
    Acta Gastroenterol Belg; 1987; 50(1):91-4. PubMed ID: 3480672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.